Home/Filings/4/0001209191-18-019095
4//SEC Filing

MCAFEE LAWRANCE W 4

Accession 0001209191-18-019095

CIK 0000885978other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 3:02 PM ET

Size

5.5 KB

Accession

0001209191-18-019095

Insider Transaction Report

Form 4
Period: 2018-03-12
MCAFEE LAWRANCE W
DirectorChief Financial Officer
Transactions
  • Sale

    Common Stock

    2018-03-12$86.06/sh2,000$172,12029,307 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.60 - $86.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]Includes 26,935 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 3,102 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 1,852 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; and 1,142 shares on each of April 1, July 1 and October 1, 2020; 1,157 shares on January 1, 2021; 632 shares on each of April 1, July 1 and October 1, 2021; and 640 shares on January 1, 2022.

Issuer

U S PHYSICAL THERAPY INC /NV

CIK 0000885978

Entity typeother

Related Parties

1
  • filerCIK 0001263096

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 3:02 PM ET
Size
5.5 KB